A Candidate Gliotransmitter, L-β-Aminoisobutyrate, Contributes to Weight Gain and Metabolic Complication Induced by Atypical Antipsychotics

Lurasidone and quetiapine are effective atypical mood-stabilizing antipsychotics, but lurasidone and quetiapine are listed as lower-risk and high-risk for weight gain/metabolic complications, respectively. The pathophysiology of the discrepancy of metabolic adverse reactions between these antipsycho...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuyama, Kouji, Motomura, Eishi, Okada, Motohiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097171/
https://www.ncbi.nlm.nih.gov/pubmed/37049464
http://dx.doi.org/10.3390/nu15071621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097171/
https://www.ncbi.nlm.nih.gov/pubmed/37049464
http://dx.doi.org/10.3390/nu15071621

Ejemplares similares